Top Gum AI Stock Analysis
Want to see IL:TPGM full AI Analyst Report?
Top Gum (TPGM) AI Stock Analysis
Top Gum
(TASE:TPGM)
Top Gum scores low primarily because of deteriorating financial fundamentals: despite strong revenue growth, the company has swung from profitability to sizeable net losses, leverage has risen sharply, and free cash flow remains negative, pointing to continued reliance on external capital. Valuation adds no cushion, with negative earnings and no dividend. The main offset is technical: the stock has stabilized above its short-term moving averages with improving momentum, though it still trades far below its 100- and 200-day averages within a longer-term downtrend. A re-rating would likely require clear evidence of margin recovery and a credible path to positive free cash flow.
Top Gum (TPGM) vs. iShares MSCI Israel ETF (EIS)
- Market Cap
- ILS 1.27B
- Dividend Yield
- ―
- Average Volume (3M)
- 145.29K
- Price to Earnings (P/E)
- -20.2
- Beta (1Y)
- 0.48
- Revenue Growth
- 58.86%
- EPS Growth
- -176.99%
- Country
- Israel
- Employees
- 379
- Sector
- General
- Sector Strength
- 55
- Industry
- Food Confectioners
Top Gum Business Overview & Revenue Model
Company Description
TopGum Industries Ltd. develops, manufactures, imports, sells, and markets dietary and nutritional supplement gummies. The company offers women’s health, beauty from within, active lifestyle, gut health, and immune support gummies. It also imports an...
Top Gum Financial Statement Overview
Summary
Financials are the weakest part of the story. Revenue has nearly quadrupled since 2021 (TTM ~₪127M, +9.7% growth), but profitability has collapsed: net losses of ₪-6.5M in 2024 and ₪-15.9M in 2025, with a TTM net loss of ₪-16.8M and negative EBIT/EBITDA margins. Gross margins of 30–35% are adequate for confectionery but cannot absorb elevated operating and financing costs. The balance sheet shows aggressive debt-funded expansion — total debt up from ₪2.4M (2021) to ₪83.5M (TTM), debt-to-equity at 0.62, and ROE at -15.8% — though equity of ~₪135M still provides a cushion. Cash flow is strained: operating cash flow is modest (~₪10.3M on ₪127M revenue) and free cash flow remains negative (TTM ₪-9.1M) due to heavy capex, leaving the company reliant on external funding.
Income Statement
25NegativeBalance Sheet
38NegativeCash Flow
28Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.67M | 100.95M | 59.27M | 45.60M | 43.91M | 33.07M |
| Gross Profit | 38.19M | 32.36M | 20.51M | 15.10M | 15.25M | 9.89M |
| EBITDA | -8.34M | -8.04M | -2.61M | 6.27M | 6.23M | 4.49M |
| Net Income | -17.94M | -15.94M | -6.49M | 3.21M | 3.63M | 1.58M |
Balance Sheet | ||||||
| Total Assets | 246.59M | 206.00M | 108.20M | 104.84M | 63.68M | 59.57M |
| Cash, Cash Equivalents and Short-Term Investments | 15.08M | 32.83M | 10.14M | 12.11M | 4.33M | 17.93M |
| Total Debt | 83.47M | 51.26M | 31.20M | 25.06M | 7.99M | 2.40M |
| Total Liabilities | 111.73M | 115.10M | 45.62M | 37.26M | 17.41M | 12.13M |
| Stockholders Equity | 134.85M | 90.90M | 62.58M | 67.59M | 46.27M | 47.44M |
Cash Flow | ||||||
| Free Cash Flow | -9.06M | -9.37M | -6.70M | -25.43M | -12.18M | -6.48M |
| Operating Cash Flow | 10.33M | 10.28M | 6.69M | 1.44M | 1.08M | 1.09M |
| Investing Cash Flow | -37.53M | -32.37M | -12.99M | -28.22M | -13.40M | -7.51M |
| Financing Cash Flow | 70.98M | 41.91M | 4.50M | 33.20M | 263.00K | 22.12M |
Top Gum Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:TPGM, the sentiment is Neutral. The current price of 950.10 is above the 20-day moving average (MA) of 890.75, below the 50-day MA of 952.14, and below the 200-day MA of 1310.60, indicating a neutral trend. The MACD of -7.61 indicates Negative momentum. The RSI at 56.10 is Neutral, neither overbought nor oversold. The STOCH value of 75.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:TPGM.
Top Gum Peers Comparison
Overall Rating
IL:ALBA72Outperform
IL:WLFD72Outperform
IL:GSFI53Neutral
IL:TPGM38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | ILS 648.75M | 8.85 | ― | 3.08% | -1.02% | 42.98% | |
| 72Outperform | ILS 697.67M | 14.49 | ― | ― | 4.06% | -21.69% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | ILS 267.40M | 20.28 | ― | 10.56% | -22.23% | -88.63% | |
| 38Underperform | ILS 1.27B | -20.23 | ― | ― | 58.86% | -176.99% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IL:TPGM | Top Gum Industries Ltd. | 950.10 | 9.80 | 1.04% | |
| IL:MEDN | Mehadrin Ltd. | 26190.00 | -3580.00 | -12.03% | |
| IL:GSFI | Gan Shmuel Foods Ltd | 1794.00 | -1184.00 | -39.76% | |
| IL:ALBA | Albaad Massuot Yitzhak Ltd. | 3383.00 | 423.00 | 14.29% | |
| IL:WLFD | Willy Food Investments Ltd. | 5372.00 | 361.00 | 7.20% | |
| IL:CRML | Carmel Corp Ltd | 1162.00 | -888.00 | -43.32% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 18, 2026
